AI주식인사이트AI Stock Insight
B

동국생명과학

303810KOSDAQ

56.0 / 100

Reference Date: 2026-10-23

Financial Score27.5 / 40
News Sentiment12.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Slightly up 3.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Dongkook Life Science is a specialized contrast agent manufacturer focusing on X-ray, CT, and MRI imaging diagnostics, with iodinated and gadolinium-based contrast agents as core products. Driven by aging populations and rising diagnostic demand, the company has expanded its market share to 22.6% in 2024. It is diversifying its portfolio through medical equipment distribution and AI medical device expansion.

Number of Employees

203people

Average Salary

64.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
8.60Industry Average 15.006.5Point

Lower than industry avg (good)

PBR
0.58Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
7.32Industry Average 8.002.5Point

Below industry avg

Debt Ratio
4.26Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20253.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼1.1% (1-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲9.5% (1-year basis)

ROE Trend
1.0 / 4

Avg ROE 5.0% (improving, 2yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 2,365Won52-week high 4,00052-week low 2,200
1-month return4.0Point

1m +3.28% (slight rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0